Literature DB >> 6303891

Effect of gastric alkalinization on serum gastrin concentrations in humans.

M N Peters, M Feldman, J H Walsh, C T Richardson.   

Abstract

Previous studies have shown that alkalinizing the stomach with sodium bicarbonate for periods up to 3 h does not cause an increase in serum gastrin concentration. We evaluated the effect of a 5-h period of continuous intragastric alkalinization on serum gastrin concentration in 12 healthy humans and 12 asymptomatic duodenal ulcer patients. On the first day, intragastric pH was maintained between 6.0 and 7.0 for 5 h by infusing 0.3 N sodium bicarbonate into the stomach. On the second day, an identical amount of sodium bicarbonate was infused intravenously while intragastric pH was permitted to remain at its natural level for 5 h. Serum gastrin concentration was also measured in each subject and patient after infusion of a homogenized steak meal. In both healthy subjects and duodenal ulcer patients, mean serum gastrin concentrations were significantly (p less than 0.05) higher after 5 h of intragastric bicarbonate infusion than after 5 h of intravenous bicarbonate infusion during which intragastric pH remained at its natural level. Increases in serum gastrin concentration with alkalinization averaged 23% and 30% of the increases in serum gastrin after a homogenized steak meal in the same subjects and patients, respectively. We conclude that continuous gastric alkalinization for 5 h increases serum gastrin concentrations in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6303891

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Effect of intravenous omeprazole on intragastric pH during intravenous infusion of amino acids.

Authors:  L C Baak; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

2.  Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; H A Tuynman; J Défize; G Pals; R R Frants; J P Straub; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

Review 3.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

Authors:  J Penston; K G Wormsley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

Review 4.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

5.  Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockade.

Authors:  O Nilsson; B Wängberg; L Johansson; E Theodorsson; A Dahlström; I M Modlin; H Ahlman
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

6.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

7.  Cholecystectomy and oesophageal pathology: is there a link?

Authors:  S Jazrawi; T N Walsh; P J Byrne; T P Hennessy
Journal:  Ir J Med Sci       Date:  1993-06       Impact factor: 1.568

8.  The association between cholecystectomy and gastroesophageal reflux symptoms: a prospective controlled study.

Authors:  Otto S Lin; Richard A Kozarek; Andrew Arai; S Ian Gan; Michael Gluck; Geoffrey C Jiranek; Kris V Kowdley; George Triadafilopoulos
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

9.  Helicobacter pylori increases gastric antral juxtamucosal pH.

Authors:  S M Kelly; J R Crampton; J O Hunter
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

10.  Effect of increasing Helicobacter pylori ammonia production by urea infusion on plasma gastrin concentrations.

Authors:  R S Chittajallu; W D Neithercut; A M Macdonald; K E McColl
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.